Stocks
Heron Therapeutics (HRTX) P/FCF US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -4.36 | -1.83 | -3.89 | -9.62 | -7.77 | -7.92 | |||
| Changes by years, y/y, % | -57% | -58% | +112% | +147% | -19% | -5.0% | |||
Heron Therapeutics. P/FCF
Heron Therapeutics. P/FCF, changes, %
Heron Therapeutics (HRTX) P/FCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/FCF | -14.2 | -10.8 | -6.89 | -7.77 | -7.27 | -7.92 | ||
| Changes by years, y/y, % | +52% | -54% | -78% | -20% | -49% | |||
| Changes by quarters, q/q, % | +47% | -24% | -36% | +13% | -6% | |||
